Literature DB >> 1380746

Androgen concentrations in expressed prostatic secretions: no correlation with tissue levels.

F K Habib1, C M Goodman, C Buck.   

Abstract

In an attempt to determine whether the androgen profiles of the prostate fluid (EPS) mirror the concentrations in the prostate tissue, we have measured testosterone and dihydrotestosterone (DHT) in EPS and correlated their levels to the concentrations found in hyperplastic prostate tissue (BPH) obtained from the same 19 patients. Although androgen concentrations in EPS were very high (testosterone = 106.7 +/- 81.9 ng/g dry weight; DHT = 54.2 +/- 11.2 ng/g dry weight), they did not reflect the concentrations measured in BPH tissue (testosterone = 7.56 +/- 1.54 ng/g dry weight; DHT = 10.54 +/- 0.63 ng/g dry weight). Additionally the accumulation of tissular DHT usually associated with BPH was not mirrored in the EPS specimens which demonstrated a relatively higher concentration of testosterone when compared to DHT. In EPS, there was also a very strong correlation between testosterone and DHT concentrations (r = 0.89; P less than 0.01). We have also measured zinc concentrations in EPS and BPH tissue but were unable to detect any relationship between the two parameters. Significantly, however, EPS zinc concentrations showed a close correlation with EPS testosterone (r = 0.73; P less than 0.01) and DHT (r = 0.69; P less than 0.01) concentrations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380746     DOI: 10.1007/bf00300259

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  11 in total

1.  DHT concentrations in human prostate cancer tissue.

Authors:  J Geller; J Albert; D Loza; S Geller; W Stoeltzing; D de la Vega
Journal:  J Clin Endocrinol Metab       Date:  1978-03       Impact factor: 5.958

2.  Hormone levels in prostatic fluid from healthy finns and prostate cancer patients.

Authors:  D P Rose; K Laakso; M Sotarauta; E L Wynder
Journal:  Eur J Cancer Clin Oncol       Date:  1984-10

3.  Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.

Authors:  P K Siiteri; J D Wilson
Journal:  J Clin Invest       Date:  1970-09       Impact factor: 14.808

4.  Zinc in post prostatic massage (VB3) urine samples: a marker of prostatic secretory function and indicator of bacterial infection.

Authors:  J P Kavanagh; C Darby; C B Costello; S D Chowdhury
Journal:  Urol Res       Date:  1983

5.  The response of seven prostatic fluid components to prostatic disease.

Authors:  J P Kavanagh; C Darby; C B Costello
Journal:  Int J Androl       Date:  1982-10

6.  Solubilization of human prostatic 5 alpha-reductase.

Authors:  B Houston; G D Chisholm; F K Habib
Journal:  J Steroid Biochem       Date:  1985-04       Impact factor: 4.292

7.  Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate.

Authors:  F K Habib; I R Lee; S R Stitch; P H Smith
Journal:  J Endocrinol       Date:  1976-10       Impact factor: 4.286

8.  Metal-androgen interrelationships in carcinoma and hyperplasia of the human prostate.

Authors:  F K Habib; G L Hammond; I R Lee; J B Dawson; M K Mason; P H Smith; S R Stitch
Journal:  J Endocrinol       Date:  1976-10       Impact factor: 4.286

9.  Sodium, potassium, calcium, magnesium, zinc, citrate and chloride content of human prostatic and seminal fluid.

Authors:  J P Kavanagh
Journal:  J Reprod Fertil       Date:  1985-09

10.  Cancer of the prostate: early diagnosis by zinc and hormone analysis?

Authors:  F K Habib; M K Mason; P H Smith; S R Stitch
Journal:  Br J Cancer       Date:  1979-06       Impact factor: 7.640

View more
  1 in total

1.  Androgens transduce the G alphas-mediated activation of protein kinase A in prostate cells.

Authors:  Gargi Bagchi; Juanjuan Wu; John French; Jae Kim; Nader H Moniri; Yehia Daaka
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.